NCT02633696View on ClinicalTrials.gov

Study to Investigate the Absolute Bioavailability of Oral Sylibin

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

silybin phosphatidylcholine

DRUG

Legalón SIL

Trial Locations (1)

28034

Hospital Ramón y Cajal, Madrid

All Listed Sponsors
collaborator

Fundación Mutua Madrileña

OTHER

lead

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

OTHER

NCT02633696 - Study to Investigate the Absolute Bioavailability of Oral Sylibin | Biotech Hunter | Biotech Hunter